Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 57
15
Diseases
152
Unique genes
0.114
Avg. similarity score
Antisocial personality disorder
Most-connected disease (7 links)
Disease
Searched: Separation anxiety disorder
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Separation anxiety disorder
Antisocial personality disorder
Orthostatic hypotension
Colchicine resistance
Familial mediterranean fever
Hepatic encephalopathy
Congenital dyserythropoietic anemia
Conduct disorder
Hyperpituitarism
Brunner syndrome
Congenital brain dysgenesis due to glutamine synthetase deficiency
Huntington disease
Nausea
severe combined immunodeficiency due to DNA-PKcs deficiency
severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Antisocial personality disorder | 7 | 7 | 4 |
| Orthostatic hypotension | 6 | 6 | 3 |
| Colchicine resistance | 5 | 5 | 1 |
| Familial mediterranean fever | 5 | 5 | 2 |
| Hepatic encephalopathy | 5 | 5 | 14 |
| Congenital dyserythropoietic anemia | 4 | 4 | 10 |
| Conduct disorder | 3 | 3 | 52 |
| Hyperpituitarism | 3 | 3 | 15 |
| Brunner syndrome | 2 | 2 | 1 |
| Congenital brain dysgenesis due to glutamine synthetase deficiency | 2 | 2 | 1 |
| Huntington disease | 2 | 2 | 61 |
| Nausea | 2 | 2 | 7 |
| Separation anxiety disorder | 2 | 2 | 1 |
| severe combined immunodeficiency due to DNA-PKcs deficiency | 1 | 1 | 1 |
| severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| ABCB1 | 7 / 15 | Antisocial personality disorder, Colchicine resistance, Congenital dyserythropoietic anemia, Familial mediterranean fever and 3 more |
| MAOA | 4 / 15 | Antisocial personality disorder, Brunner syndrome, Hepatic encephalopathy, Huntington disease |
| DRD4 | 3 / 15 | Antisocial personality disorder, Conduct disorder, Separation anxiety disorder |
| GLUL | 3 / 15 | Congenital brain dysgenesis due to glutamine synthetase deficiency, Hepatic encephalopathy, Huntington disease |
| OPRM1 | 3 / 15 | Hepatic encephalopathy, Nausea, Orthostatic hypotension |
| CNR1 | 2 / 15 | Conduct disorder, Huntington disease |
| GATAD2B | 2 / 15 | Conduct disorder, severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome |
| HTR1B | 2 / 15 | Antisocial personality disorder, Conduct disorder |
| MAD1L1 | 2 / 15 | Conduct disorder, Hyperpituitarism |
| MAOB | 2 / 15 | Hepatic encephalopathy, Huntington disease |
| PRKDC | 2 / 15 | Hepatic encephalopathy, severe combined immunodeficiency due to DNA-PKcs deficiency |
| TNF | 2 / 15 | Hepatic encephalopathy, Nausea |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Alcoholic liver disease | KEGG | 10 / 144 | 5.5× | 1.41e-5 | 4.72e-4 ✓ sig. |
| Neuroactive ligand-receptor interaction | KEGG | 15 / 370 | 3.2× | 6.95e-5 | 1.74e-3 ✓ sig. |
| Synaptic adhesion-like molecules | Reactome | 4 / 21 | 15.1× | 1.25e-4 | 2.77e-3 ✓ sig. |
| GABAergic synapse | KEGG | 7 / 89 | 6.2× | 1.31e-4 | 2.88e-3 ✓ sig. |
| Nicotine addiction | KEGG | 5 / 41 | 9.6× | 1.58e-4 | 3.33e-3 ✓ sig. |
| Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB | Reactome | 2 / 2 | 79.0× | 1.59e-4 | 3.35e-3 ✓ sig. |
| Cocaine addiction | KEGG | 5 / 49 | 8.1× | 3.70e-4 | 6.54e-3 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 7 / 108 | 5.1× | 4.34e-4 | 7.43e-3 ✓ sig. |
| Opioid Signalling | Reactome | 2 / 3 | 52.7× | 4.73e-4 | 7.95e-3 ✓ sig. |
| GABA receptor activation | Reactome | 3 / 16 | 14.8× | 9.86e-4 | 1.39e-2 ✓ sig. |
| Tyrosine metabolism | KEGG | 4 / 36 | 8.8× | 1.06e-3 | 1.47e-2 ✓ sig. |
| Amphetamine addiction | KEGG | 5 / 69 | 5.7× | 1.78e-3 | 2.18e-2 ✓ sig. |
| Adipocytokine signaling pathway | KEGG | 5 / 70 | 5.6× | 1.90e-3 | 2.28e-2 ✓ sig. |
| Assembly and cell surface presentation of NMDA receptors | Reactome | 2 / 6 | 26.3× | 2.31e-3 | 2.63e-2 ✓ sig. |
| Necroptosis | KEGG | 7 / 159 | 3.5× | 4.07e-3 | 3.93e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of apoptotic process | GO:0043065 | 16 / 326 | 6.0× | 1.03e-8 | 1.74e-6 ✓ sig. |
| cell surface receptor signaling pathway via STAT | GO:0097696 | 6 / 28 | 26.3× | 8.52e-8 | 1.07e-5 ✓ sig. |
| cellular response to hydrogen peroxide | GO:0070301 | 7 / 69 | 12.5× | 1.45e-6 | 1.15e-4 ✓ sig. |
| regulation of neuronal synaptic plasticity | GO:0048168 | 5 / 26 | 23.6× | 1.91e-6 | 1.44e-4 ✓ sig. |
| chemical synaptic transmission | GO:0007268 | 11 / 236 | 5.7× | 3.75e-6 | 2.46e-4 ✓ sig. |
| G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | GO:0007187 | 6 / 54 | 13.7× | 4.91e-6 | 3.04e-4 ✓ sig. |
| negative regulation of apoptotic process | GO:0043066 | 16 / 524 | 3.8× | 5.95e-6 | 3.57e-4 ✓ sig. |
| protein destabilization | GO:0031648 | 6 / 60 | 12.3× | 9.14e-6 | 5.04e-4 ✓ sig. |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 5 / 36 | 17.1× | 1.03e-5 | 5.50e-4 ✓ sig. |
| vascular endothelial growth factor production | GO:0010573 | 3 / 6 | 61.5× | 1.04e-5 | 5.55e-4 ✓ sig. |
| response to hypoxia | GO:0001666 | 9 / 176 | 6.3× | 1.41e-5 | 7.07e-4 ✓ sig. |
| positive regulation of glial cell proliferation | GO:0060252 | 4 / 22 | 22.4× | 2.75e-5 | 1.18e-3 ✓ sig. |
| exploration behavior | GO:0035640 | 4 / 25 | 19.7× | 4.66e-5 | 1.77e-3 ✓ sig. |
| positive regulation of chemokine production | GO:0032722 | 5 / 49 | 12.5× | 4.76e-5 | 1.80e-3 ✓ sig. |
| negative regulation of neuron apoptotic process | GO:0043524 | 8 / 160 | 6.1× | 5.01e-5 | 1.87e-3 ✓ sig. |